What investors want to see is Tonix Pharmaceuticals ( TNXP) move away from a cash-burning R&D company and into having more of a recurring revenue base from its current approved drugs. As of now, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback